Recent Insider Transactions - CASI Pharmaceuticals (NASDAQ: CASI)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CASI CASI Pharmaceuticals

Zukiwski Alexander A / officer: EVP and Chief Medical Officer

09/07/2022

Buy

$15.20

3,000

$46K

3,000

NASDAQ CASI CASI Pharmaceuticals

Huang James / director:

09/06/2022

Buy

$4.28

33,300

$143K

371,517

NASDAQ CASI CASI Pharmaceuticals

Huang James / director:

08/31/2022

Buy

$3.74

400

$1K

315,944

NASDAQ CASI CASI Pharmaceuticals

Huang James / director:

08/24/2022

Buy

$3.75

39,527

$148K

278,748

NASDAQ CASI CASI Pharmaceuticals

Huang James / director:

08/19/2022

Buy

$3.50

40,000

$140K

234,221

NASDAQ CASI CASI Pharmaceuticals

He Wei-Wu / director, 10 percent owner, officer: Chairman and CEO

06/15/2022

Buy

$3.18

50,000

$159K

644,553

NASDAQ CASI CASI Pharmaceuticals

He Wei-Wu / officer: Chairman and CEO

06/13/2022

Buy

$3.06

2,096

$6K

594,553

NASDAQ CASI CASI Pharmaceuticals

He Wei-Wu / director, 10 percent owner, officer: Chairman and CEO

06/13/2022

Buy

$2.97

36,058

$107K

592,457

NASDAQ CASI CASI Pharmaceuticals

Zhou Quan / director

05/25/2022

Buy

$0.47

380,645

$178K

380,645

NASDAQ CASI CASI Pharmaceuticals

Wu Yue Alexander / director

05/25/2022

Buy

$0.47

388,387

$181K

388,387

NASDAQ CASI CASI Pharmaceuticals

Salisbury Franklin Cary jr / director

05/25/2022

Buy

$0.47

388,387

$181K

388,387